Tag: Drug Approvals
FDA Approves Ninlaro for Multiple Myeloma
New oral medication blocks certain enzymes, hindering cancer-cell growth
FDA Approves Narcan Nasal Spray to Counter Opioid Overdose
First-of-its-kind drug sanctioned to reverse effects of heroin or oxycodone use
FDA Approves Cotellic for Advanced Melanoma
For patients whose tumors express BRAF V600E or V600K mutations
FDA Approves Genvoya to Treat HIV-1 Infection
Medication contains a new form of tenofovir not previously approved by the FDA
FDA Approves Expanded Use for Melanoma Drug
Yervoy can now be used after surgery to reduce risk of skin cancer returning
FDA Approves Imlygic for Melanoma
Injectable drug designed to rupture and kill cancer cells
FDA Approves Onivyde for Metastatic Pancreatic Cancer
To be used in combination with fluorouracil/leucovorin for advanced disease
FDA Approves Yondelis for Soft-Tissue Sarcoma
Drug sanctioned for liposarcoma or leiomyosarcoma
FDA Approves Coagadex for Rare Clotting Disorder
First coagulation therapy sanctioned for Factor X deficiency
FDA Approves Praxbind to Reverse Pradaxa’s Effect
Praxbind cleared for emergency use with Pradaxa when bleeding can't be controlled
